Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Annals of the Rheumatic Diseases
|
January 28, 2025
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Journal of Medical Internet Research
|
July 23, 2024
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial
Johannes Knitza, Koray Tascilar, Franziska Fuchs, et al.
Annals of the Rheumatic Diseases
|
April 27, 2021
X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)
Christina Bergmann, Ludwig Hallenberger, Sara Chenguiti Fakhouri, et al.
Annals of the Rheumatic Diseases
|
July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging
Christian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
Arthritis Research & Therapy
|
April 14, 2021
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial
Johannes Knitza, Jacob Mohn, Christina Bergmann, et al.
The Lancet. Rheumatology
|
May 3, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
Melanie Hagen, Fabian Müller, Andreas Wirsching, et al.
The Lancet. Rheumatology
|
August 15, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus - Authors' reply
Melanie Hagen, Fabian Müller, Andreas Wirsching, et al.
The Lancet. Rheumatology
|
January 27, 2024
<sup>68</sup>Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study
Christina Bergmann, Jörg H W Distler, Christoph Treutlein, et al.
The Journal of Clinical Investigation
|
May 15, 2024
Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis
Thuong Trinh-Minh, Chih-Wei Chen, Cuong Tran Manh, et al.
Rheumatology (Oxford, England)
|
January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort
Eliane Roth, Cosimo Bruni, Liubov Petelytska, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Annals of the Rheumatic Diseases
|
January 28, 2025
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Journal of Medical Internet Research
|
July 23, 2024
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial
Johannes Knitza, Koray Tascilar, Franziska Fuchs, et al.
Annals of the Rheumatic Diseases
|
April 27, 2021
X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)
Christina Bergmann, Ludwig Hallenberger, Sara Chenguiti Fakhouri, et al.
Annals of the Rheumatic Diseases
|
July 29, 2020
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging
Christian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
Arthritis Research & Therapy
|
April 14, 2021
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial
Johannes Knitza, Jacob Mohn, Christina Bergmann, et al.
The Lancet. Rheumatology
|
May 3, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
Melanie Hagen, Fabian Müller, Andreas Wirsching, et al.
The Lancet. Rheumatology
|
August 15, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus - Authors' reply
Melanie Hagen, Fabian Müller, Andreas Wirsching, et al.
The Lancet. Rheumatology
|
January 27, 2024
<sup>68</sup>Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study
Christina Bergmann, Jörg H W Distler, Christoph Treutlein, et al.
The Journal of Clinical Investigation
|
May 15, 2024
Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis
Thuong Trinh-Minh, Chih-Wei Chen, Cuong Tran Manh, et al.
Rheumatology (Oxford, England)
|
January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort
Eliane Roth, Cosimo Bruni, Liubov Petelytska, et al.
Page
of 11